» Articles » PMID: 27048451

Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2016 Apr 7
PMID 27048451
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Large-volume total paracentesis may result in paracentesis-induced circulatory dysfunction, which is associated with poor outcomes.

Aims: To explore the short- and long-term effects of paracentesis-induced circulatory dysfunction on systemic hemodynamics, renal function and other cirrhosis-related complications in patients with refractory ascites, following subtotal large-volume paracentesis.

Methods: Patients with cirrhosis and refractory ascites without renal dysfunction had systemic hemodynamics, renal function, and neurohormones (plasma active renin, aldosterone, norepinephrine and angiotensin II) measured pre- and 6 days post-paracentesis. Paracentesis was limited to ≤8 L with 6-8 g of albumin per liter ascites drained. Patients were followed up until transjugular intrahepatic portosystemic shunt insertion, liver transplantation, or death. Paracentesis-induced circulatory dysfunction was defined as >50 % increase in plasma active renin 6 days post-paracentesis.

Results: Fifty-seven patients (mean age 59.0 ± 9.4 years) had mean 6.8 ± 1.8 L of ascites removed with 9 ± 3 g of albumin given/L of ascites drained. Patients were followed up for 715 ± 104 days. Twenty-three patients (40.4 %) developed paracentesis-induced circulatory dysfunction with unchanged serum creatinine on day six, despite worsening of hemodynamics (mean arterial pressure 90 ± 10 mmHg at baseline vs. 84 ± 8 mmHg on day six, p < 0.05). Similar hemodynamic changes were observed among patients without paracentesis-induced circulatory dysfunction. There was no significant difference in the long-term renal function or cirrhosis-related complications between the groups.

Conclusion: The occurrence of paracentesis-induced circulatory dysfunction, as defined by plasma active renin, may not have a significant short- and long-term impact on renal function or cirrhosis-related complications in patients with refractory ascites who undergo subtotal paracentesis with albumin infusion.

Citing Articles

Drainage of ascites in cirrhosis.

Yang J, Peng Y, Zeng H, Lin X, Xu Z World J Hepatol. 2024; 16(9):1245-1257.

PMID: 39351514 PMC: 11438587. DOI: 10.4254/wjh.v16.i9.1245.


Management of refractory ascites.

Wong F Clin Mol Hepatol. 2022; 29(1):16-32.

PMID: 35676862 PMC: 9845666. DOI: 10.3350/cmh.2022.0104.


Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites.

Wong Y, Lum H, Tan P, Teo E, Tan J, Kumar R Singapore Med J. 2021; 62(12):659-664.

PMID: 33866716 PMC: 8804429. DOI: 10.11622/smedj.2021049.


HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan.

Ali B, Salim A, Alam A, Zuberi B, Ali Z, Azam Z Pak J Med Sci. 2020; 36(5):1117-1132.

PMID: 32704299 PMC: 7372671. DOI: 10.12669/pjms.36.5.2407.


Nutrition in Chronic Liver Disease.

Reddy Y, Maliakkal B, Agbim U Curr Treat Options Gastroenterol. 2019; 17(4):602-618.

PMID: 31673924 DOI: 10.1007/s11938-019-00252-3.


References
1.
. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53(3):397-417. DOI: 10.1016/j.jhep.2010.05.004. View

2.
Peltekian K, Wong F, Liu P, Logan A, Sherman M, Blendis L . Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol. 1997; 92(3):394-9. View

3.
Boyer J, Thanigaraj S, Schechtman K, Perez J . Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004; 93(7):870-5. DOI: 10.1016/j.amjcard.2003.12.026. View

4.
Unger N, Lopez Schmidt I, Pitt C, Walz M, Philipp T, Mann K . Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol. 2004; 150(4):517-23. DOI: 10.1530/eje.0.1500517. View

5.
Bernardi M, Caraceni P, Navickis R, Wilkes M . Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2011; 55(4):1172-81. DOI: 10.1002/hep.24786. View